Experience with second allogeneic hematopoietic stem cell transplantation in Chilean patients: A single-center study
A second allogeneic transplantation may offer a survival benefit in selected patients with relapsed hematologic malignancies or bone marrow failure syndromes. Despite high non-relapse mortality, outcomes have improved in recent years with better salvage strategies.
Authors
- Catherine Gutiérrez
- Mauricio Sarmiento (ORCID: https://orcid.org/0000-0003-3715-9886)
- Vicente Sandoval (ORCID: https://orcid.org/0000-0001-8044-1567)
- Yorman Flores (ORCID: https://orcid.org/0009-0001-9920-9861)
- Mauricio Ocqueteau
- Verónica Jara
- Patricio Rojas (ORCID: https://orcid.org/0000-0002-7221-6738)
- Felipe Palacios
- Marcela Vidal
- José Salinas
- María José García (ORCID: https://orcid.org/0000-0002-6517-7005)
- Maximiliano Vergara (ORCID: https://orcid.org/0000-0002-0957-9122)
- Elizabeth Rivera
- Javier Díaz
Institutions
- Pontificia Universidad Católica de Chile (CL)
Publication Details
- Journal
- Hematology Transfusion and Cell Therapy
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.htct.2025.103980
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00